Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis

被引：3
|
作者：
De Maria, Costanza [1 ,2 ]
Ghidotti, Ilaria [1 ,2 ]
Grillo, Federica [2 ,3 ]
Giannini, Edoardo G. [1 ,2 ]
机构：
[1] Univ Genoa, Gastroenterol Unit, Dept Internal Med, Viale Benedetto XV,6, I-16132 Genoa, Italy
[2] Osped Policlin San Martino IRCCS Oncol, Genoa, Italy
[3] Univ Genoa, Dept Surg Sci, Pathol Unit, Genoa, Italy
来源：
DIGESTIVE DISEASES AND SCIENCES | 2019年 / 64卷 / 02期
关键词：
Autoimmune hepatitis; Azathioprine; Hepatitis C virus; Cirrhosis; Direct-acting antivirals; Outcome; INTERFERON;
D O I：
10.1007/s10620-018-5356-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：591 / 593
页数：3
相关论文
共 50 条
  • [21] Autoimmune reactions in the course of the hepatitis C virus (HCV) infection
    Tomasiewicz, Krzysztof
    Pokora-Pachowicz, Agnieszka
    Kiciak, Slawomir
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 1 (02) : 39 - 43
  • [22] Successful Immunosuppression Titration in Patient With Refractory Autoimmune Hepatitis and Severe COVID-19 Infection
    Siudela, Anthony
    Montminy, Eric M.
    Moehlen, Martin
    Regenstein, Fredric
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1402 - S1403
  • [23] A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature
    Androutsakos, Theodoros
    Stamopoulos, Paraskevas
    Aroni, Kiriaki
    Hatzis, Gregorios
    BMC GASTROENTEROLOGY, 2015, 15
  • [24] A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature
    Theodoros Androutsakos
    Paraskevas Stamopoulos
    Kiriaki Aroni
    Gregorios Hatzis
    BMC Gastroenterology, 15
  • [25] Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab- Bevacizumab for hepatocellular carcinoma
    Stella, L.
    Cabibbo, G.
    Iavarone, M.
    Piscaglia, F.
    Tovoli, F.
    Marra, F.
    Mazzarelli, C.
    Tortora, R.
    Aghemo, A.
    De Nicola, S.
    Bhoori, S.
    Pallozzi, M.
    Gasbarrini, A.
    Cerrito, L.
    Ponziani, F. R.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [26] Treatment of acute HCV infection with direct acting antivirals (DAA) in HIV patients
    Gomez-Ayerbe, C.
    Palacios, R.
    Perez, C.
    Tellez, F.
    Sayago, C.
    Rios, M. J.
    Martin-Aspas, A.
    Camacho, A.
    Munoz, L.
    Santos, J.
    HIV MEDICINE, 2019, 20 : 298 - 298
  • [27] Changes of AFP and PIVKA-II levels during DAA treatment and their predictive value for early diagnosis of HCC in HCV cirrhotic patients with SVR to DAA treatment
    Sangiovanni, A.
    D'Ambrosio, R.
    Lunghi, G.
    Bruccoleri, M.
    Alimenti, E.
    Borghi, M.
    Perbellini, R.
    Aghemo, A.
    Iavarone, M.
    Colombo, M.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 49 - 49
  • [28] Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
    Roguljic, Hrvoje
    Nincevic, Vjera
    Bojanic, Kristina
    Kuna, Lucija
    Smolic, Robert
    Vcev, Aleksandar
    Primorac, Dragan
    Vceva, Andrijana
    Wu, George Y.
    Smolic, Martina
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [29] Treatment of acute HCV infection with direct acting antivirals (DAA) in HIV patients
    Gomez-Ayerbe, C.
    Palacios, R.
    Tellez, F.
    Sayago, C.
    Rios, M.
    Martin-Aspas, A.
    Camacho, A.
    Munoz, L.
    Santos, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [30] The clinical outcome and safety of generic DAA treatment for HCV infection in Vietnam in 2016
    Vu, H. T. T.
    Ishizaki, A.
    Nguyen, Q. T.
    Nguyen, H. N.
    Le, H. T.
    Nguyen, T. V.
    Nguyen, K. V.
    Ichimura, H.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 61 - 62
12345